Munetaka Takekuma

Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial

Ana Oaknin, Laurence Gladieff, Jerónimo Martínez-García et al. · The Lancet · 2023 · 175 citations

Oncology, Cervical Cancer, Metronomic Therapy +6

Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy-D-glucose

Tatsuo Torizuka, Shuji Nobezawa, Toshihiko Kanno et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2002 · 136 citations

Positron Emission Tomography, Radiology, Engineering +9

Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET.

Tatsuo Torizuka, Toshihiko Kanno, Masami Futatsubashi et al. · PubMed · 2003 · 109 citations

Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma

Koji Matsuo, Yutaka Takazawa, Malcolm S. Ross et al. · Annals of Oncology · 2016 · 102 citations · Full text

Tumoral Pathology, Sarcoma Components, Medicine +10

A new marker, insulinoma-associated protein 1 (INSM1), for high-grade neuroendocrine carcinoma of the uterine cervix: Analysis of 37 cases

Shiho Kuji, Reiko Watanabe, Yuichi Sato et al. · Gynecologic Oncology · 2016 · 83 citations

Insulinoma-associated Protein 1, Neuroendocrine Disorder, New Marker +6